Clinico-biological trajectories stratified by combined tau biomarkers in preclinical Alzheimer’s disease
Abstract Background Tau pathology biomarkers provide prognostic indicators of neurodegeneration and cognitive decline in Alzheimer’s disease (AD), making them crucial to early patient stratification for disease-modifying interventions. Plasma p-tau217 indexes early tau pathophysiology, whereas FDA/E...
Uloženo v:
| Hlavní autoři: | , , , , |
|---|---|
| Médium: | Artigo |
| Jazyk: | Inglês |
| Vydáno: |
BMC
2026-06-01
|
| Edice: | Alzheimer’s Research & Therapy |
| Témata: | |
| On-line přístup: | https://doi.org/10.1186/s13195-026-02123-3 |
| Tagy: |
Žádné tagy, Buďte první, kdo vytvoří štítek k tomuto záznamu!
|